Vascular Biogenics Ltd. | CIK:0001603207 | 3

  • Filed: 3/15/2018
  • Entity registrant name: Vascular Biogenics Ltd. (CIK: 0001603207)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1603207/000149315218003377/0001493152-18-003377-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1603207/000149315218003377/vblt-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001603207
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory

      i. Expenses for share based compensation recognized in statements of comprehensive loss were as follows:

     

       

    Year ended

    December 31

     
        2017     2016     2015  
       

    U.S. dollars

    in thousands

     
    Research and development expenses   $ 2,027     $ 900     $ 385  
    Administrative and general expenses     1,977       520       656  
    Marketing expenses     148              
                             
        $ 4,152     $ 1,420     $ 1,041